TrialNature communications2016

Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma.

Jeffrey J Wallin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.